What do “molecules” have to do with the way we think, feel, and behave? How do “molecules” mediate actions in our everyday life? How can we utilize this information when treating patients suffering from mental conditions? We strive to find answers for these fundamental questions.
The Molecular Psychiatry Program (MPP) at Johns Hopkins University is an interdisciplinary program endeavoring to address these questions through clinical, research, and educational activities.
We utilize many resources available at Johns Hopkins to perform multifaceted research. These approaches include molecular biology, neuroscience, biomedical engineering, human genetics, and clinical epidemiology together tackling science in a comprehensive manner.
We support many clinical fellows and basic science scholars (e.g., postdoctoral fellows) who share an interest in the interface of clinical psychiatry and basic science. We also mentor students from three graduate programs, such as Cellular and Molecular Medicine (CMM), Human Genetics, and Neuroscience. Our program aims to study the brain at the interface of clinical psychiatry and basic science.
The MPP program also maintains clinical responsibilities at Johns Hopkins Medicine, mainly linking to the Johns Hopkins Schizophrenia Center. Several clinician scientists are involved in patient care, emphasizing schizophrenia and mood disorders.
Akira Sawa, M.D., Ph.D.
Director, Molecular Psychiatry Program
Director, Johns Hopkins Schizophrenia Center
Professor, Department of Psychiatry and Behavioral Sciences
Department of Neuroscience, Graduate Program in Cellular and Molecular Medicine, Graduate Program in Human Genetics